On this page
ZBH Zimmer Biomet Holdings, Inc. Common Stock
NYSE · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 5, 2026
$88.29
· of 52w range
· above low
· to high
$79.1252w low
$106.8852w high
Market Cap (MRQ)
$28.20B
P/E (TTM)
21.4
EPS (TTM)
$4.12
Revenue (TTM)
$8.51B
your badges
52W Range
$79–$107
Analyst Rating
HOLD
Price Target
$108
P/E
21.4
ROE
6.4%
Net Profit Margin
9.5%
Your badge strip is empty — pin a metric anywhere on this page.
ZBH Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$88.29
Market Cap (MRQ)
$28.20B
P/E (TTM)
21.4
EPS (TTM)
$4.12
Revenue (TTM)
$8.51B
Div Yield
0.67%
ROE (TTM)
6.4%
Debt/Equity (MRQ)
0.6
52W Range
$79–$107
ZBH Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| March 1, 2022 | 103-for-100 | Forward |
About Zimmer Biomet Holdings, Inc. Common Stock Company overview from Wikipedia
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. (ExtraOrtho). In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet.
On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook.
History
Zimmer Biomet was established in 1927 by Justin O. Zimmer (1884–1951) in Warsaw, Indiana.
On April 24, 2014, it was announced that Zimmer had agreed to purchase Biomet Inc. for $13.4 billion. In October 2014, however, it was announced that the EU's antitrust regulators had opened an extensive investigation into Zimmer's bid for Biomet due to concern that it would substantially lessen competition in certain markets. In March 2016, European Commission (“EC”) conditionally cleared Zimmer's proposed acquisition of Biomet, Inc. and on June 24, 2015, Zimmer completed its acquisition of Biomet forming Zimmer Biomet Holdings.
In October 2014, the company announced it would acquire ETEX Holdings, Inc.
In March 2016, Zimmer Biomet announced it would acquire Ortho Transmission, LLC. The company also announced it would acquire sports medicine company, Cayenne Medical, Inc. Later in the same year the company acquired medical device manufacturer, LDR Holding Corporation for $37 per share ($1 billion in total), merging it into their Spine division. In July, the company acquired French surgical robotics company Medtech. In August, the company announced it was acquiring Delaware-based CD Diagnostics, a diagnostics company developing immunoassays and biomarker testing. In September, Zimmer announced the acquisition of Clinical Graphics, B.V.
The Justin Zimmer House in Warsaw is listed on the National Register of Historic Places.
In January 2023, the company announced its intention to acquire Embody, Inc. for $155 million (plus a potential $120 million in milestones).
In August 2024, Zimmer Biomet announced plans to acquire OrthoGrid Systems, an AI surgical guidance company, in order to expand its market share in hip replacement procedures.
In 2026, Zimmer Biomet acquired the iovera pain therapy business from Pacira BioSciences Inc. for $140 million.
Products
Zimmer designs, develops, manufactures and markets orthopedics products, including knee, hip, shoulder, elbow, foot and ankle artificial joints and dental prostheses. In 2024, Zimmer introduced the ROSA Shoulder, said to be the world's first robotic surgery system for shoulder replacement, and the fourth application for the company's ROSA Robotics portfolio, which includes the ROSA Knee System for total knee arthroplasty and ROSA Hip System for total hip replacement. Zimmer has operations in more than 40 countries around the world (US, Australia, Austria, Belgium, Canada, China, Czech Republic, Finland, France, Germany, India, Ireland, Israel, Italy, Japan, Latin America, Netherlands, Brasil, Poland, Portugal, Russia, South Africa, Spain etc.) and sells products in more than 100 countries.
Acquisition history
The following is an illustration of the company's major mergers, acquisitions and historical predecessors:
Company data
Zimmer's 2023 sales were approximately $7.4 billion. The company has approximately 18,000 employees worldwide.
Leadership
Raymond Elliott was president and CEO from August 2001 to May 2007.
David C. Dvorak, was president and CEO from May 1, 2007, to July 11, 2017.
Dan Florin, Interim President and CEO from July 11, 2017, to December 19, 2017.
Bryan C. Hanson, President and CEO from December 19, 2017 to August 22, 2023.
Ivan Tornos, President and CEO from August 22, 2023, to present.
Recognition
In 2016, the company was recognized on the Fortune 500 list for the first time, ranking in position #431. As of 2026, the company is ranked 463rd on the list.
Criticism
During the 2022 Russian invasion of Ukraine, Zimmer Biomet continued to sell to the Russian market. Research from Yale University updated on April 28, 2022, identifying how companies were reacting to Russia's invasion identified Zimmer Biomet as continuing business-as-usual in Russia: companies defying demands for exit/reduction of activities.
Public-private engagement
Activism
Zimmer Biomet is a corporate partner of Human Rights Campaign, a large LGBT advocacy organization.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
sectorHealth Care
industryHealth Care
employees17,000
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$8.23B2016-12-31 → 2025-12-31
EPS$3.552016-12-31 → 2025-12-31
Free Cash Flow$1.47B2016-12-31 → 2025-12-31
Net margin9.5%2016-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ZBH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 21.45Y avg ≈50.9 | ≈50.9 | 28.6 | Undervalued | |
| P/S (TTM) | 3.35Y avg ≈4.9 | ≈4.9 | 4.4 | Undervalued | |
| P/B (MRQ) | 2.25Y avg ≈2.9 | ≈2.9 | 4.7 | Undervalued | |
| EV / EBITDA | 16.05Y avg ≈21.1 | ≈21.1 | 17.3 | Undervalued | |
| Price / FCF (TTM) | 18.55Y avg ≈27.7 | ≈27.7 | · | · | |
| Price / Cash Flow (TTM) | 16.25Y avg ≈23.8 | ≈23.8 | 21.9 | Undervalued | |
| EV / Revenue | 4.35Y avg ≈5.7 | ≈5.7 | · | · | |
| EV / FCF | 23.85Y avg ≈32.2 | ≈32.2 | · | · | |
| Price / Tangible Book (MRQ) | 3.5 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ZBH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | 14.2%5Y avg ≈13.5% | ≈13.5% | 15.6% | In line | |
| EBITDA Margin (TTM) | 27.2%5Y avg ≈26.7% | ≈26.7% | 15.6% | In line | |
| Pretax Margin (TTM) | 11.0%5Y avg ≈9.8% | ≈9.8% | 14.0% | Weak | |
| Net Profit Margin (TTM) | 9.5%5Y avg ≈8.5% | ≈8.5% | 11.2% | Weak | |
| ROA (TTM) | 3.5%5Y avg ≈3.0% | ≈3.0% | 8.0% | Weak | |
| ROE (TTM) | 6.4%5Y avg ≈5.3% | ≈5.3% | 14.8% | Weak | |
| ROIC | 4.6%5Y avg ≈4.8% | ≈4.8% | 10.9% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ZBH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.65Y avg ≈0.5 | ≈0.5 | 0.2 | High debt | |
| Current Ratio (MRQ) | 1.75Y avg ≈1.8 | ≈1.8 | 1.8 | Low liquidity | |
| Quick Ratio | 0.95Y avg ≈0.7 | ≈0.7 | 0.9 | Low liquidity | |
| Long-Term Debt / Equity (MRQ) | 0.55Y avg ≈0.4 | ≈0.4 | 0.5 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | ZBH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 7.2%5Y avg ≈6.1% | ≈6.1% | · | · | |
| Revenue CAGR 3Y | 5.9%5Y avg ≈5.4% | ≈5.4% | · | · | |
| Revenue CAGR 5Y | 6.1% | · | · | · | |
| EPS YoY | -19.9%5Y avg ≈68.0% | ≈68.0% | · | · | |
| Net Income YoY | -22.0%5Y avg ≈66.6% | ≈66.6% | · | · | |
| EPS CAGR 3Y | 47.8% | · | · | · | |
| Net Income CAGR 3Y | 45.0% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | ZBH | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.45Y avg ≈0.3 | ≈0.3 | 0.6 | Weak | |
| Inventory Turnover | 1.15Y avg ≈1.0 | ≈1.0 | 2.4 | Weak | |
| Receivables Turnover | 5.25Y avg ≈5.3 | ≈5.3 | 6.2 | Weak | |
| Revenue / Employee | ≈$484.2K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
Dividend Yield0.67%
Payout Ratio27.0%
Annualized Payout≈$0.96
5Y Div CAGR≈0.59%
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Jun 25, 2026 | $0.24 | USD | ≈1.1% |
| Mar 31, 2026 | $0.24 | USD | ≈1.1% |
| Dec 30, 2025 | $0.24 | USD | ≈1.1% |
| Sep 30, 2025 | $0.24 | USD | ≈0.97% |
| Jun 26, 2025 | $0.24 | USD | ≈1.0% |
| Mar 31, 2025 | $0.24 | USD | ≈0.85% |
| Dec 30, 2024 | $0.24 | USD | ≈0.91% |
| Sep 30, 2024 | $0.24 | USD | ≈0.89% |
| Jun 26, 2024 | $0.24 | USD | ≈0.89% |
| Mar 27, 2024 | $0.24 | USD | ≈0.72% |
| Dec 26, 2023 | $0.24 | USD | ≈0.79% |
| Sep 28, 2023 | $0.24 | USD | ≈0.85% |
| Jun 23, 2023 | $0.24 | USD | ≈0.67% |
| Mar 28, 2023 | $0.24 | USD | ≈0.76% |
| Dec 23, 2022 | $0.24 | USD | ≈0.76% |
| Sep 29, 2022 | $0.24 | USD | ≈0.89% |
| Jun 24, 2022 | $0.24 | USD | ≈0.87% |
| Mar 28, 2022 | $0.24 | USD | ≈0.75% |
| Dec 27, 2021 | $0.23 | USD | ≈0.75% |
| Sep 29, 2021 | $0.23 | USD | ≈0.64% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
3.0%
Next Report
Nov 03, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 5, 2026 | $2.07 | $2.03 | 2.0% |
| March 31, 2026 | $2.09 | $1.88 | 11.0% | |
| Dec. 31, 2025 | $2.42 | $2.42 | 0.00% | |
| Sept. 30, 2025 | $1.90 | $1.89 | 0.73% | |
| June 30, 2025 | $2.07 | $2.00 | 3.3% | |
| March 31, 2025 | $1.81 | $1.79 | 1.2% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B | $6.13B | $7.98B | $7.93B | $7.80B | $7.67B | $6.00B | $4.67B | |
| Cost of Revenue | $2.49B | $2.19B | $2.08B | $2.02B | $1.96B | $1.82B | $2.25B | $2.27B | $2.13B | $2.38B | $1.80B | $1.24B | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | $3.42B | |
| SG&A Expense | $3.26B | $2.93B | $2.84B | $2.76B | $2.84B | $2.71B | $3.34B | $3.38B | $3.10B | $2.94B | $2.28B | $1.75B | |
| Operating Expenses | $7.13B | $6.39B | $6.12B | $6.24B | $5.97B | $6.04B | $6.84B | $7.90B | $7.00B | $6.85B | $5.53B | $3.64B | |
| Operating Income | $1.10B | $1.29B | $1.28B | $696M | $860M | $83M | $1.14B | $34M | $799M | $821M | $467M | $1.04B | |
| Interest Income | · | · | · | · | · | · | · | · | $2M | $3M | $9M | $12M | |
| Other Non-op | $26M | $-31M | $-9M | $-128M | $12M | $24M | $-5M | $-16M | $-9M | $-66M | $-37M | $-47M | |
| Pretax Income | $831M | $1.04B | $1.07B | $404M | $499M | $-105M | $906M | $-271M | $465M | $400M | $153M | $939M | |
| Income Tax | $126M | $131M | $42M | $112M | $54M | $-96M | $-226M | $108M | $-1.35B | $95M | $7M | $220M | |
| Net Income | $705M | $904M | $1.02B | $231M | $402M | $-139M | $1.13B | $-379M | $1.81B | $306M | $147M | $720M | |
| EPS (Basic) | $3.56 | $4.45 | $4.91 | $1.10 | $1.93 | $-0.67 | $5.52 | $-1.86 | $8.98 | $1.53 | $0.78 | $4.26 | |
| EPS (Diluted) | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 | $-0.67 | $5.47 | $-1.86 | $8.90 | $1.51 | $0.77 | $4.20 | |
| Shares (Basic) | 198,000,000 | 203,100,000 | 208,700,000 | 209,600,000 | 208,600,000 | 207,000,000 | 205,100,000 | 203,500,000 | 201,900,000 | 200,000,000 | 187,400,000 | 169,000,000 | |
| Shares (Diluted) | 198,700,000 | 203,900,000 | 209,700,000 | 210,300,000 | 210,400,000 | 207,000,000 | 206,700,000 | 203,500,000 | 203,700,000 | 202,400,000 | 189,800,000 | 171,700,000 | |
| EBITDA | $2.19B | $2.28B | $2.23B | $1.62B | $1.85B | $945M | $2.14B | $1.07B | $1.87B | $1.87B | $1.18B | $1.41B |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $592M | $526M | $416M | $376M | $378M | $802M | $618M | $543M | $524M | $634M | $1.46B | $1.08B | |
| Receivables | $1.70B | $1.48B | $1.44B | $1.38B | $1.26B | $1.45B | $1.36B | $1.28B | $1.54B | $1.60B | $1.45B | $912M | |
| Inventory | $2.29B | $2.24B | $2.39B | $2.15B | $2.15B | $2.45B | $2.38B | $2.26B | $2.07B | $1.96B | $2.25B | $1.19B | |
| Prepaid Expense | $537M | $430M | $366M | $523M | $271M | $169M | $357M | $352M | $428M | $466M | $529M | $317M | |
| Current Assets | $5.12B | $4.67B | $4.61B | $4.43B | $4.88B | $5.08B | $4.72B | $4.43B | $4.56B | $4.66B | $5.85B | $4.31B | |
| PP&E (Net) | $2.21B | $2.05B | $2.06B | $1.87B | $1.84B | $2.05B | $2.08B | $2.02B | $2.04B | $2.04B | $2.06B | $1.29B | |
| PP&E (Gross) | $7.26B | $6.69B | $6.77B | $6.46B | $6.14B | $6.32B | $5.92B | $5.44B | $5.08B | $4.67B | $4.43B | $3.41B | |
| Accum. Depreciation | $5.05B | $4.64B | $4.71B | $4.59B | $4.30B | $4.28B | $3.84B | $3.42B | $3.05B | $2.63B | $2.37B | $2.12B | |
| Goodwill | $9.95B | $8.95B | $8.82B | $8.58B | $8.92B | $8.98B | $9.60B | $9.59B | $10.67B | $10.64B | $9.93B | $2.51B | |
| Intangibles | $4.72B | $4.60B | $4.86B | $5.06B | $5.53B | $7.06B | $7.26B | $7.68B | $8.35B | $8.79B | $8.75B | $604M | |
| Other Non-current Assets | $1.10B | $1.10B | $1.15B | $1.12B | $1.00B | $969M | $980M | $405M | $389M | $554M | $564M | $942M | |
| Total Assets | $23.09B | $21.37B | $21.50B | $21.07B | $23.46B | $24.42B | $24.64B | $24.13B | $26.01B | $26.68B | $27.16B | $9.66B | |
| Accounts Payable | $303M | $195M | $411M | $354M | $306M | $330M | $401M | $363M | $330M | $364M | $285M | $145M | |
| Accrued Liabilities | $834M | $706M | $804M | $582M | $536M | $873M | $778M | $671M | $775M | $789M | $726M | $351M | |
| Current Liabilities | $2.58B | $2.45B | $2.86B | $2.36B | $3.47B | $2.56B | $3.44B | $2.42B | $3.07B | $2.38B | $1.62B | $1.02B | |
| Capital Leases | $176M | $190M | $174M | $167M | $175M | $218M | $216M | · | · | · | · | · | |
| Deferred Tax | $244M | $352M | $358M | $475M | $558M | $790M | $840M | $1000M | $1.10B | $3.03B | $3.15B | $46M | |
| Other Non-current Liabilities | $626M | $744M | $926M | $633M | $548M | $656M | $558M | $350M | $446M | $463M | $1.01B | $611M | |
| Total Liabilities | $10.39B | $8.89B | $9.01B | $9.04B | $10.79B | $12.22B | $12.25B | $12.85B | $14.28B | $17.01B | $17.27B | $3.11B | |
| Long-term Debt | $7.52B | $6.20B | $5.77B | $5.70B | $1.00B | $8.13B | $8.22B | $8.94B | $10.14B | $11.24B | · | · | |
| Total Debt | $7.52B | $6.20B | $5.77B | $5.70B | $7.07B | $8.13B | $8.22B | $8.94B | $10.14B | $11.24B | $11.56B | $1.43B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Retained Earnings | $11.61B | $11.10B | $10.38B | $9.56B | $10.29B | $10.09B | $10.43B | $9.49B | $10.02B | $8.47B | $8.35B | $8.36B | |
| Treasury Stock | $8.89B | $8.41B | $7.56B | $6.87B | $6.72B | $6.72B | $6.72B | $6.72B | $6.72B | $6.74B | $6.33B | $6.18B | |
| AOCI | $-206M | $-263M | $-191M | $-179M | $-232M | $-298M | $-242M | $-187M | $-83M | $-434M | $-329M | $38M | |
| Stockholders' Equity | $12.70B | $12.47B | $12.48B | $12.02B | $12.66B | $12.19B | $12.39B | $11.27B | $11.74B | $9.67B | $9.89B | $6.55B | |
| Liabilities + Equity | $23.09B | $21.37B | $21.50B | $21.07B | $23.46B | $24.42B | $24.64B | $24.13B | $26.01B | $26.68B | $27.16B | $9.66B | |
| Shares Outstanding | 318,700,000 | 317,500,000 | 316,200,000 | 313,800,000 | 312,800,000 | 311,400,000 | 309,900,000 | 307,900,000 | 306,500,000 | 304,700,000 | 302,700,000 | 268,400,000 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.09B | $996M | $952M | $926M | $938M | $898M | $1.01B | $1.04B | $1.06B | $1.04B | $712M | $376M | |
| Stock-based Comp | $90M | $101M | $100M | $105M | $76M | $74M | $84M | $66M | $54M | $57M | $46M | $49M | |
| Deferred Tax | $-87M | $-48M | $-96M | $-64M | $-102M | $39M | $-539M | $13M | $-1.78B | $-153M | $-164M | $-90M | |
| Amort. of Intangibles | $666M | $592M | $562M | $527M | $530M | $512M | $584M | $596M | $604M | $566M | $337M | $92M | |
| Restructuring | · | · | · | · | $32M | · | · | · | $17M | $91M | $196M | · | |
| Other Non-cash | $-105M | $-454M | $-398M | $158M | $95M | $219M | $-98M | $1.01B | $428M | $383M | $75M | $-8M | |
| Operating Cash Flow | $1.70B | $1.50B | $1.58B | $1.36B | $1.40B | $1.08B | $1.59B | $1.75B | $1.58B | $1.63B | $850M | $1.06B | |
| CapEx | $224M | $204M | $291M | $188M | $144M | $112M | $207M | $163M | $156M | $185M | $168M | $145M | |
| Investing Cash Flow | $-1.98B | $-888M | $-779M | · | $-504M | $-614M | $-729M | $-417M | $-511M | $-1.69B | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $750M | $3.00B | · | |
| Net Debt Issued | · | · | · | · | · | · | · | $-1.43B | $-940M | $-50M | $2.50B | · | |
| Stock Repurchased | $487M | $868M | $692M | $126M | · | · | · | · | · | $416M | $150M | $401M | |
| Net Stock Activity | $-487M | $-868M | $-692M | $-126M | · | · | · | · | · | $-416M | $-150M | $-400M | |
| Dividends Paid | $190M | $196M | $201M | $201M | $200M | $198M | $197M | $195M | $194M | $188M | $157M | $146M | |
| Financing Cash Flow | $326M | $-484M | $-764M | · | $-1.31B | $-422M | $-780M | $-1.30B | $-1.21B | $-743M | · | · | |
| Net Change in Cash | $66M | $110M | $40M | $-103M | $-324M | $184M | $75M | $18M | $-110M | $-825M | $376M | $3M | |
| Taxes Paid | $377M | $328M | $215M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.47B | $1.30B | $1.29B | $1.17B | $1.33B | $1.09B | $1.38B | $1.58B | $1.43B | $1.45B | $649M | $908M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | 73.3% | |
| Operating Margin | 13.3% | 16.7% | 17.3% | 10.0% | 10.0% | -1.2% | 14.2% | 0.43% | 10.3% | 10.8% | 7.8% | 22.1% | |
| Net Margin | 8.6% | 11.8% | 13.9% | 3.3% | 5.1% | -2.0% | 14.2% | -4.8% | 23.2% | 4.0% | 2.5% | 15.4% | |
| Pretax Margin | 10.1% | 13.5% | 14.4% | 5.8% | 5.3% | -3.9% | 11.3% | -3.4% | 5.9% | 5.2% | 2.5% | 20.2% | |
| EBITDA Margin | 26.6% | 29.7% | 30.1% | 23.4% | 23.6% | 13.5% | 26.9% | 13.5% | 23.9% | 24.3% | 19.7% | 30.2% | |
| ROA | 3.2% | 4.2% | 4.8% | 1.0% | 1.7% | -0.57% | 4.6% | -1.5% | 6.9% | 1.1% | 0.54% | 7.5% | |
| ROE | 5.6% | 7.2% | 8.4% | 1.9% | 3.2% | -1.1% | 9.6% | -3.3% | 17.0% | 3.1% | 1.5% | 11.2% | |
| ROIC | 4.6% | 6.0% | 6.7% | 2.8% | 3.8% | -0.22% | 6.9% | 0.23% | 14.4% | 3.0% | 2.1% | 9.9% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.9 | 1.6 | 1.9 | 1.4 | 2.0 | 1.4 | 1.8 | 1.5 | 2.0 | 3.6 | 4.1 | |
| Quick Ratio | 0.9 | 0.8 | 0.7 | 0.7 | 0.5 | 0.9 | 0.6 | 0.8 | 0.7 | 0.9 | 1.8 | 1.9 | |
| Debt / Equity | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | 0.9 | 1.2 | 1.2 | 0.2 | |
| LT Debt / Equity | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | 0.5 | 0.7 | 0.8 | 1.1 | 1.2 | 0.2 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.5 | |
| Inventory Turnover | 1.1 | 0.9 | 0.9 | 0.9 | 1.0 | 0.9 | 1.0 | 1.1 | 1.1 | 1.1 | 0.8 | 1.1 | |
| Receivables Turnover | 5.2 | 5.3 | 5.2 | 5.3 | 5.5 | 5.0 | 6.0 | 5.6 | 5.0 | 5.0 | 5.1 | 5.1 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $39.84 | $39.27 | $39.47 | $38.31 | $40.48 | $39.16 | $39.97 | $36.61 | $38.29 | $31.73 | $32.67 | · | |
| Revenue / Share | $41.43 | $37.66 | $35.26 | $33.00 | $37.24 | $33.93 | $38.62 | $38.98 | $38.41 | $37.96 | $31.60 | $27.22 | |
| Cash Flow / Share | $8.54 | $7.35 | $7.54 | $6.45 | $7.13 | $5.82 | $7.67 | $8.59 | $7.77 | $8.06 | $4.30 | $6.13 | |
| Cash / Share | $1.86 | $1.66 | $1.31 | $1.20 | $1.53 | $2.58 | $1.99 | $1.76 | $1.71 | $2.08 | $4.82 | · | |
| Dividend / Share | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.88 | $0.88 | |
| EPS (TTM) | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 | $-0.67 | $5.47 | $-1.86 | $8.90 | $1.51 | $0.77 | $4.20 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.2% | 3.9% | 6.6% | 1.7% | 11.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.9% | 4.0% | 6.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -19.9% | -9.2% | 343.6% | -42.4% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 47.8% | 32.4% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -22.0% | -11.7% | 342.5% | -42.4% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 45.0% | 31.1% | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | -0.84% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B | $6.13B | $7.98B | $7.93B | $7.80B | $7.67B | $6.00B | $4.67B | |
| Net Income TTM | $705M | $904M | $1.02B | $231M | $402M | $-139M | $1.13B | $-379M | $1.81B | $306M | $147M | $720M | |
| Market Cap | $28.66B | $33.54B | $38.48B | $40.01B | $38.58B | $46.59B | $45.03B | $31.01B | $35.91B | $30.53B | $30.15B | · | |
| Enterprise Value | $35.58B | $39.22B | $43.83B | $45.33B | $45.17B | $53.91B | $52.64B | $39.40B | $45.53B | $41.14B | $40.25B | · | |
| P/E | 25.3 | 23.8 | 24.9 | 115.9 | 64.6 | -223.3 | 26.6 | -54.1 | 13.2 | 66.4 | 129.4 | 26.2 | |
| P/S | 3.5 | 4.4 | 5.2 | 5.8 | 5.7 | 7.6 | 5.6 | 3.9 | 4.6 | 4.0 | 5.0 | · | |
| P/B | 2.3 | 2.7 | 3.1 | 3.3 | 3.0 | 3.8 | 3.6 | 2.8 | 3.1 | 3.2 | 3.0 | · | |
| P / Cash Flow | 16.9 | 22.4 | 24.3 | 29.5 | 25.7 | 38.7 | 28.4 | 17.7 | 22.7 | 18.7 | 36.9 | · | |
| P / FCF | 19.5 | 25.9 | 29.8 | 34.2 | 29.1 | 42.9 | 32.7 | 19.6 | 25.2 | 21.1 | 46.5 | · | |
| EV / EBITDA | 16.2 | 17.2 | 19.7 | 27.9 | 24.4 | 57.1 | 24.6 | 36.7 | 24.3 | 22.1 | 34.1 | · | |
| EV / FCF | 24.2 | 30.3 | 34.0 | 38.8 | 34.0 | 49.6 | 38.2 | 24.9 | 31.9 | 28.4 | 62.0 | · | |
| EV / Revenue | 4.3 | 5.1 | 5.9 | 6.5 | 6.6 | 8.8 | 6.6 | 5.0 | 5.8 | 5.4 | 6.7 | · | |
| Dividend Yield | 0.66% | 0.58% | 0.52% | 0.50% | 0.52% | 0.43% | 0.44% | 0.63% | 0.54% | 0.62% | 0.52% | · | |
| Earnings Yield | 4.0% | 4.2% | 4.0% | 0.86% | 1.6% | -0.45% | 3.8% | -1.8% | 7.6% | 1.5% | 0.77% | 3.8% | |
| Payout Ratio | 27.0% | 21.7% | 19.6% | 87.0% | 49.8% | -142.9% | 17.4% | -51.5% | 10.7% | 61.6% | 106.9% | 20.2% | |
| Annual Payout | $190M | $196M | $201M | $201M | $200M | $198M | $197M | $195M | $194M | $188M | $157M | $146M |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.18B | $2.09B | $2.24B | $2.00B | $2.08B | $1.91B | $2.02B | $1.82B | $1.94B | $1.89B | $1.94B | $1.75B | $1.87B | $1.83B | $1.83B | $1.67B | |
| Cost of Revenue | $636M | $576M | $792M | $559M | $592M | $550M | $587M | $539M | $554M | $512M | $539M | $519M | $526M | $501M | $520M | $488M | |
| SG&A Expense | $899M | $850M | $872M | $811M | $815M | $759M | $747M | $710M | $737M | $736M | $722M | $675M | $726M | $716M | $727M | $655M | |
| Operating Expenses | $1.85B | $1.71B | $2.09B | $1.65B | $1.78B | $1.62B | $1.63B | $1.54B | $1.59B | $1.62B | $1.59B | $1.49B | $1.54B | $1.50B | $1.85B | $1.42B | |
| Operating Income | $326M | $373M | $154M | $351M | $300M | $292M | $389M | $280M | $351M | $266M | $354M | $267M | $330M | $327M | $-28M | $245M | |
| Other Non-op | $2M | $-3M | $15M | $3M | $4M | $3M | $-38M | $5M | $2M | $-100.0K | $-20M | $4M | $-1M | $8M | $-4M | $-25M | |
| Pretax Income | $255M | $301M | $98M | $279M | $225M | $229M | $289M | $230M | $302M | $215M | $284M | $219M | $277M | $287M | $-75M | $178M | |
| Income Tax | $56M | $63M | $-40M | $48M | $71M | $46M | $49M | $-19M | $59M | $42M | $-135M | $56M | $67M | $54M | $55M | $-17M | |
| Net Income | $198M | $238M | $139M | $231M | $153M | $182M | $240M | $249M | $243M | $172M | $419M | $163M | $210M | $232M | $-130M | $194M | |
| EPS (Basic) | $1.03 | $1.22 | $0.70 | $1.17 | $0.77 | $0.92 | $1.20 | $1.23 | $1.18 | $0.84 | $2.02 | $0.78 | $1.00 | $1.11 | $-0.62 | $0.92 | |
| EPS (Diluted) | $1.03 | $1.22 | $0.71 | $1.16 | $0.77 | $0.91 | $1.18 | $1.23 | $1.18 | $0.84 | $2.00 | $0.77 | $1.00 | $1.11 | $-0.62 | $0.92 | |
| Shares (Basic) | 192,200,000 | 195,000,000 | · | 198,100,000 | 197,900,000 | 198,900,000 | · | 202,300,000 | 205,700,000 | 205,200,000 | · | 208,900,000 | 208,600,000 | 209,400,000 | · | 209,800,000 | |
| Shares (Diluted) | 192,800,000 | 195,800,000 | · | 198,800,000 | 198,300,000 | 199,700,000 | · | 203,000,000 | 206,400,000 | 206,200,000 | · | 210,000,000 | 209,900,000 | 210,400,000 | · | 210,300,000 | |
| EBITDA | $326M | $643M | · | $351M | $300M | $547M | · | $280M | $351M | $504M | · | $267M | $330M | $559M | · | $245M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $410M | $424M | $592M | $1.29B | $557M | $1.38B | $526M | $569M | $420M | $393M | · | $292M | $320M | $330M | · | $545M | |
| Receivables | $1.77B | $1.73B | $1.70B | $1.60B | $1.61B | $1.53B | $1.48B | $1.48B | $1.42B | $1.45B | · | $1.34B | $1.37B | $1.38B | · | $1.28B | |
| Inventory | $2.27B | $2.25B | $2.29B | $2.48B | $2.45B | $2.24B | $2.24B | $2.37B | $2.37B | $2.39B | · | $2.32B | $2.28B | $2.24B | · | $2.13B | |
| Prepaid Expense | $647M | $563M | $537M | $460M | $431M | $428M | $430M | $445M | $431M | $404M | · | $416M | $425M | $460M | · | $347M | |
| Current Assets | $5.10B | $4.96B | $5.12B | $5.83B | $5.05B | $5.59B | $4.67B | $4.86B | $4.64B | $4.63B | · | $4.37B | $4.39B | $4.41B | · | $4.53B | |
| PP&E (Net) | $2.24B | $2.21B | $2.21B | $2.19B | $2.18B | $2.06B | $2.05B | $2.11B | $2.10B | $2.09B | · | $2.03B | $1.98B | $1.91B | · | $1.80B | |
| PP&E (Gross) | $7.42B | $7.30B | $7.26B | $7.22B | $7.15B | $6.82B | $6.69B | $6.90B | $6.74B | $6.85B | · | $6.65B | $6.72B | $6.59B | · | $6.34B | |
| Accum. Depreciation | $5.18B | $5.09B | $5.05B | $5.03B | $4.97B | $4.76B | $4.64B | $4.79B | $4.64B | $4.76B | · | $4.61B | $4.74B | $4.69B | · | $4.54B | |
| Goodwill | $9.92B | $9.93B | $9.95B | $9.70B | $9.71B | $8.99B | $8.95B | $8.91B | $8.82B | $8.79B | $8.82B | $8.71B | $8.74B | $8.73B | $8.58B | $8.80B | |
| Intangibles | $4.46B | $4.55B | $4.72B | $4.74B | $4.89B | $4.47B | $4.60B | $4.67B | $4.71B | $4.73B | · | $4.89B | $5.03B | $5.07B | · | $5.14B | |
| Other Non-current Assets | $1.08B | $1.07B | $1.10B | $1.02B | $1.04B | $1.07B | $1.10B | $1.17B | $1.25B | $1.20B | · | $1.21B | $1.16B | $1.12B | · | $1.06B | |
| Total Assets | $22.80B | $22.72B | $23.09B | $23.49B | $22.87B | $22.18B | $21.37B | $21.72B | $21.52B | $21.45B | · | $21.22B | $21.29B | $21.24B | · | $21.33B | |
| Accounts Payable | $352M | $361M | $303M | $315M | $349M | $301M | $195M | $322M | $342M | $370M | · | $320M | $355M | $397M | · | $334M | |
| Accrued Liabilities | · | · | $834M | · | · | · | $706M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $3.01B | $2.86B | $2.58B | $2.40B | $2.70B | $2.29B | $2.45B | $3.57B | $3.61B | $2.80B | · | $2.07B | $2.23B | $2.34B | · | $2.30B | |
| Capital Leases | · | · | $176M | · | · | · | $190M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $236M | $250M | $244M | · | · | · | $352M | · | · | $370M | · | $465M | $475M | $485M | · | $541M | |
| Other Non-current Liabilities | $639M | $631M | $626M | $806M | $879M | $909M | $744M | $1.03B | $1.21B | $577M | · | $632M | $642M | $637M | · | $609M | |
| Total Liabilities | $10.17B | $10.04B | $10.39B | $10.72B | $10.33B | $9.78B | $8.89B | $9.34B | $8.77B | $8.85B | · | $8.70B | $8.92B | $9.09B | · | $9.08B | |
| Long-term Debt | $7.48B | $7.47B | $7.52B | $8.11B | $7.57B | $7.18B | $6.20B | $6.45B | $5.83B | $5.80B | · | $5.48B | $5.71B | $5.79B | · | $5.71B | |
| Total Debt | $7.48B | $7.47B | · | $8.11B | $7.57B | $7.18B | · | $6.45B | $5.83B | $5.80B | · | $5.48B | $5.71B | $5.79B | · | $5.71B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Retained Earnings | $11.96B | $11.80B | $11.61B | $11.52B | $11.34B | $11.23B | $11.10B | $10.90B | $10.70B | $10.51B | · | $10.01B | $9.90B | $9.74B | · | $9.74B | |
| Treasury Stock | $9.39B | $9.14B | $8.89B | $8.64B | $8.64B | $8.64B | $8.41B | $8.35B | $7.74B | $7.65B | · | $7.12B | $7.12B | $7.11B | · | $6.72B | |
| AOCI | $-164M | $-190M | $-206M | $-284M | $-284M | $-287M | $-263M | $-202M | $-195M | $-211M | · | $-186M | $-178M | $-178M | · | $-245M | |
| Stockholders' Equity | $12.62B | $12.67B | $12.70B | $12.76B | $12.53B | $12.40B | $12.47B | $12.37B | $12.74B | $12.60B | · | $12.51B | $12.37B | $12.15B | · | $12.24B | |
| Liabilities + Equity | $22.80B | $22.72B | $23.09B | $23.49B | $22.87B | $22.18B | $21.37B | $21.72B | $21.52B | $21.45B | · | $21.22B | $21.29B | $21.24B | · | $21.33B | |
| Shares Outstanding | 319,400,000 | 319,300,000 | 318,700,000 | 318,700,000 | 318,400,000 | 318,400,000 | 317,500,000 | 317,400,000 | 317,200,000 | 317,200,000 | 316,200,000 | 316,000,000 | 315,800,000 | 315,400,000 | 313,800,000 | 313,600,000 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $271M | $270M | $284M | $284M | $272M | $254M | $264M | $251M | $243M | $239M | $241M | $241M | $238M | $232M | $228M | $231M | |
| Stock-based Comp | $25M | $24M | $24M | $25M | $21M | $20M | $21M | $24M | $26M | $29M | $25M | $16M | $34M | $25M | $27M | $27M | |
| Amort. of Intangibles | $163M | $162M | $178M | $176M | $161M | $151M | $158M | $148M | $144M | $142M | $145M | $145M | $138M | $133M | $132M | $132M | |
| Other Non-cash | · | $-173M | · | · | · | $-73M | · | · | · | $-212M | · | · | · | $-182M | · | · | |
| Operating Cash Flow | $448M | $359M | $517M | $419M | $378M | $383M | $506M | $396M | $369M | $228M | $588M | $338M | $348M | $308M | $244M | $451M | |
| CapEx | $54M | $36M | $75M | $55M | $50M | $45M | $52M | $44M | $53M | $55M | $63M | $84M | $97M | $47M | $63M | $47M | |
| Investing Cash Flow | $-191M | $-159M | $-322M | $-163M | $-1.38B | $-106M | $-291M | $-155M | $-247M | $-195M | $-221M | $-166M | $-243M | $-149M | · | · | |
| Stock Repurchased | $251M | $250M | $250M | $0 | $7M | $230M | $72M | $596M | $86M | $114M | $410M | $0 | $14M | $268M | · | · | |
| Net Stock Activity | · | $-250M | · | · | · | $-230M | · | · | · | $-114M | · | · | · | $-268M | · | · | |
| Dividends Paid | $46M | $47M | $48M | $48M | $48M | $48M | $48M | $49M | $49M | $49M | $50M | $50M | $50M | $50M | $50M | $50M | |
| Financing Cash Flow | $-271M | $-369M | $-897M | $484M | $164M | $575M | $-241M | $-102M | $-92M | $-50M | $-251M | $-196M | $-109M | $-207M | · | · | |
| Net Change in Cash | $-14M | $-168M | $-701M | $736M | $-828M | $859M | $-44M | $149M | $27M | $-23M | $124M | $-28M | $-10M | $-46M | $-170M | $159M | |
| Free Cash Flow | · | $323M | · | · | · | $338M | · | · | · | $173M | · | · | · | $261M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.0% | 17.9% | · | 17.5% | 14.4% | 15.3% | · | 15.3% | 18.1% | 14.1% | · | 15.2% | 17.6% | 17.9% | · | 14.7% | |
| Net Margin | 9.1% | 11.4% | · | 11.5% | 7.4% | 9.5% | · | 13.7% | 12.5% | 9.1% | · | 9.3% | 11.2% | 12.7% | · | 11.6% | |
| Pretax Margin | 11.7% | 14.4% | · | 14.0% | 10.8% | 12.0% | · | 12.6% | 15.6% | 11.4% | · | 12.5% | 14.8% | 15.7% | · | 10.6% | |
| EBITDA Margin | 15.0% | 30.8% | · | 17.5% | 14.4% | 28.6% | · | 15.3% | 18.1% | 26.7% | · | 15.2% | 17.6% | 30.5% | · | 14.7% | |
| ROA | 0.87% | 1.1% | · | 1.0% | 0.69% | 0.83% | · | 1.2% | 1.1% | 0.81% | · | 0.76% | 0.98% | 1.1% | · | 0.86% | |
| ROE | 1.6% | 1.9% | · | 1.8% | 1.2% | 1.5% | · | 2.0% | 1.9% | 1.4% | · | 1.3% | 1.7% | 1.9% | · | 1.6% | |
| ROIC | 1.3% | 1.5% | · | 1.4% | 1.0% | 1.2% | · | 1.6% | 1.5% | 1.2% | · | 1.1% | 1.4% | 1.5% | · | 1.5% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.7 | · | 2.4 | 1.9 | 2.4 | · | 1.4 | 1.3 | 1.7 | · | 2.1 | 2.0 | 1.9 | · | 2.0 | |
| Quick Ratio | 0.7 | 0.8 | · | 1.2 | 0.8 | 1.3 | · | 0.6 | 0.5 | 0.7 | · | 0.8 | 0.8 | 0.7 | · | 0.8 | |
| Debt / Equity | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | 0.3 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.3 | 1.4 | 1.3 | · | 1.3 | 1.4 | 1.3 | · | 1.3 | 1.4 | 1.4 | · | 1.3 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $39.52 | $39.69 | · | $40.03 | $39.34 | $38.93 | · | $38.99 | $40.17 | $39.72 | · | $39.59 | $39.18 | $38.52 | · | $39.05 | |
| Revenue / Share | $11.29 | $10.66 | · | $10.07 | $10.48 | $9.56 | · | $8.99 | $9.41 | $9.16 | · | $8.35 | $8.91 | $8.70 | · | $7.94 | |
| Cash Flow / Share | · | $1.84 | · | · | · | $1.92 | · | · | · | $1.11 | · | · | · | $1.46 | · | · | |
| Cash / Share | $1.28 | $1.33 | · | $4.06 | $1.75 | $4.35 | · | $1.79 | $1.32 | $1.24 | · | $0.92 | $1.01 | $1.05 | · | $1.74 | |
| Dividend / Share | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | |
| EPS (TTM) | $4.12 | $3.86 | · | $4.02 | $4.09 | $4.50 | · | $5.25 | $4.79 | $4.61 | · | $2.26 | $2.41 | $2.14 | · | $1.33 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8.51B | $8.41B | · | $8.01B | $7.83B | $7.70B | · | $7.60B | $7.52B | $7.45B | · | $7.28B | $7.20B | $7.11B | · | $6.89B | |
| Net Income TTM | $807M | $761M | · | $805M | $823M | $913M | · | $1.08B | $997M | $964M | · | $474M | $506M | $450M | · | $278M | |
| Market Cap | $27.50B | $28.87B | · | $31.39B | $29.04B | $36.04B | · | $34.26B | $34.43B | $41.86B | · | $35.46B | $45.98B | $40.75B | · | $32.79B | |
| Enterprise Value | $34.57B | $35.92B | · | $38.21B | $36.06B | $41.83B | · | $40.15B | $39.84B | $47.27B | · | $40.65B | $51.37B | $46.21B | · | $37.96B | |
| P/E | 20.9 | 23.4 | · | 24.5 | 22.3 | 25.2 | · | 20.6 | 22.7 | 28.6 | · | 49.7 | 60.4 | 60.4 | · | 78.6 | |
| P/S | 3.2 | 3.4 | · | 3.9 | 3.7 | 4.7 | · | 4.5 | 4.6 | 5.6 | · | 4.9 | 6.4 | 5.7 | · | 4.8 | |
| P/B | 2.2 | 2.3 | · | 2.5 | 2.3 | 2.9 | · | 2.8 | 2.7 | 3.3 | · | 2.8 | 3.7 | 3.4 | · | 2.7 | |
| P / Cash Flow | · | 80.3 | · | · | · | 94.1 | · | · | · | 183.6 | · | · | · | 132.4 | · | · | |
| EV / Revenue | 4.1 | 4.3 | · | 4.8 | 4.6 | 5.4 | · | 5.3 | 5.3 | 6.3 | · | 5.6 | 7.1 | 6.5 | · | 5.5 | |
| Dividend Yield | 0.69% | 0.66% | · | 0.61% | 0.66% | 0.54% | · | 0.58% | 0.58% | 0.48% | · | 0.57% | 0.44% | 0.49% | · | 0.61% | |
| Earnings Yield | 4.8% | 4.3% | · | 4.1% | 4.5% | 4.0% | · | 4.9% | 4.4% | 3.5% | · | 2.0% | 1.7% | 1.7% | · | 1.3% | |
| Payout Ratio | · | 19.7% | · | · | · | 26.3% | · | · | · | 28.6% | · | · | · | 21.6% | · | · | |
| Annual Payout | $188M | $189M | · | $191M | $192M | $194M | · | $198M | $199M | $200M | · | $201M | $201M | $201M | · | $201M |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B |
| Operating Margin % | 13.3% | 16.7% | 17.3% | 10.0% | 10.0% |
| Net Income | $705M | $904M | $1.02B | $231M | $402M |
| Diluted EPS | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 |
| Current Ratio | 2.0 | 1.9 | 1.6 | 1.9 | 1.4 |
| Quick Ratio | 0.9 | 0.8 | 0.7 | 0.7 | 0.5 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $1.47B | $1.30B | $1.29B | $1.17B | $1.33B |
Institutional owners (13F) 976 filers · $18.6B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
976
Value held
$18.6B
New positions
89
Exited positions
81
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 89 (-27 vs prior Q) | 81 (-21 vs prior Q) | 313 (+13 vs prior Q) | 303 (+4 vs prior Q) | +9.4M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $2,111,657,991 | 23,483,741 | 11.35% | Shares |
| Dodge & Cox | $2,076,898,436 | 24,124,735 | 11.17% | Shares |
| BlackRock, Inc. | $1,344,282,175 | 15,614,847 | 7.23% | Shares |
| HARRIS ASSOCIATES L P | $1,096,616,595 | 12,738,025 | 5.90% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $1,087,741,726 | 12,634,937 | 5.85% | Shares |
| Capital International Investors | $1,048,887,329 | 12,183,614 | 5.64% | Shares |
| STATE STREET CORP | $766,342,640 | 8,877,171 | 4.12% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $726,749,999 | 8,441,747 | 3.91% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $458,747,478 | 5,349,223 | 2.47% | Shares |
| Invesco Ltd. | $342,626,146 | 3,979,860 | 1.84% | Shares |
| PRIMECAP MANAGEMENT CO/CA/ | $328,577,983 | 3,816,680 | 1.77% | Shares |
| VAN ECK ASSOCIATES CORP | $301,457,394 | 3,501,654 | 1.62% | Shares |
| CITADEL ADVISORS LLC | $299,375,565 | 3,477,472 | 1.61% | Shares |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $237,731,423 | 2,761,429 | 1.28% | Shares |
| UBS Group AG | $237,489,165 | 2,758,615 | 1.28% | Shares |
| AMERICAN CENTURY COMPANIES INC | $236,270,951 | 2,744,463 | 1.27% | Shares |
| MORGAN STANLEY | $223,102,705 | 2,591,503 | 1.20% | Shares |
| BANK OF AMERICA CORP /DE/ | $187,480,282 | 2,177,724 | 1.01% | Shares |
| NORTHERN TRUST CORP | $169,171,326 | 1,965,052 | 0.91% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $168,672,488 | 1,958,313 | 0.91% | Shares |
| EQUITY INVESTMENT CORP | $144,748,296 | 1,681,360 | 0.78% | Shares |
| NORGES BANK | $136,661,935 | 1,587,431 | 0.73% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $134,484,547 | 1,562,139 | 0.72% | Shares |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $132,937,293 | 1,470,220 | 0.71% | Shares |
| Legal & General Group Plc | $126,167,392 | 1,465,529 | 0.68% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $125,541,517 | 1,458,259 | 0.67% | Shares |
| Vestal Point Capital, LP | $120,526,000 | 1,400,000 | 0.65% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $118,554,797 | 1,377,103 | 0.64% | Shares |
| Holocene Advisors, LP | $101,367,617 | 1,177,461 | 0.54% | Shares |
| VICTORY CAPITAL MANAGEMENT INC | $99,065,937 | 1,150,725 | 0.53% | Shares |
| Bank of New York Mellon Corp | $95,820,351 | 1,113,025 | 0.52% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $93,508,375 | 1,086,170 | 0.50% | Shares |
| Camber Capital Management LP | $91,210,000 | 1,000,000 | 0.49% | Shares |
| AMERIPRISE FINANCIAL INC | $89,620,025 | 1,040,975 | 0.48% | Shares |
| GOLDMAN SACHS GROUP INC | $83,389,162 | 968,628 | 0.45% | Shares |
| TORONTO DOMINION BANK | $81,590,162 | 947,731 | 0.44% | Shares |
| Woodline Partners LP | $81,122,607 | 942,300 | 0.44% | Shares |
| DEUTSCHE BANK AG\ | $79,508,592 | 923,552 | 0.43% | Shares |
| Point72 Asset Management, L.P. | $75,746,373 | 879,851 | 0.41% | Shares |
| RAYMOND JAMES FINANCIAL INC | $74,568,500 | 866,170 | 0.40% | Shares |
| JPMORGAN CHASE & CO | $74,444,065 | 815,914 | 0.40% | Shares |
| Sound Shore Management Inc /CT/ | $68,407,286 | 794,602 | 0.37% | Shares |
| CAUSEWAY CAPITAL MANAGEMENT LLC | $67,908,650 | 788,810 | 0.37% | Shares |
| Quantinno Capital Management LP | $62,169,005 | 722,139 | 0.33% | Shares |
| Amundi | $61,922,729 | 719,279 | 0.33% | Shares |
| Boston Partners | $61,088,392 | 709,202 | 0.33% | Shares |
| Meridiem Capital Partners LP | $54,973,200 | 638,555 | 0.30% | Shares |
| SHAPIRO CAPITAL MANAGEMENT LLC | $52,119,833 | 605,411 | 0.28% | Shares |
| BANK OF MONTREAL /CAN/ | $49,368,266 | 573,449 | 0.27% | Shares |
| Magellan Asset Management Ltd | $49,106,511 | 570,409 | 0.26% | Shares |
Activists & 5%+ owners 6 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc., Honey Badger Merger Sub, Inc. | July 15, 2025 | 27.00% | Initial filing | M&A / sale | SEC |
| KKR Biomet LLC, KKR 2006 Fund L.P., OPERF Co-Investment LLC, KKR PEI Investments, L.P., 8 North America Investor L.P., KKR Partners III, L.P., KKR Associates 2006 LP, KKR 2006 GP LLC, KKR PEI Associates, L.P., KKR PEI GP Limited, KKR Associates 8 NA L.P., KKR 8 NA Limited, KKR III GP LLC, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, Henry R. Kravis, George R. Roberts ×3 filings | June 16, 2016 | · | Initial filing | · | SEC |
| TPG Group Holdings (SBS) Advisors, Inc., David Bonderman, James G. Coulter ×3 filings | June 16, 2016 | · | Initial filing | Capital structure | SEC |
| Blackstone Capital Partners V, L.P., Blackstone Capital Partners V-AC L.P., BCP V-S L.P., Blackstone Family Investment Partnership V L.P., Blackstone Family Investment Partnership V-SMD L.P., Blackstone Participation Partnership V L.P., BCP V Co-Investors L.P., Blackstone Management Associates V L.L.C., BMA V L.L.C., BCP V Side-By-Side GP L.L.C., Blackstone Family GP L.L.C., Blackstone Holdings III L.P., Blackstone Holdings III GP L.P., Blackstone Holdings III GP Management L.L.C., The Blackstone Group L.P., Blackstone Group Management L.L.C., Stephen A. Schwarzman ×3 filings | Feb. 12, 2016 | · | Initial filing | · | SEC |
| LVB Acquisition Holding, LLC ×2 filings | Feb. 9, 2016 | · | Initial filing | · | SEC |
| Zimmer Holdings, Inc., Zimmer, Inc., Zimmer CEP USA Holding Co. ×3 filings | Aug. 10, 2006 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 62 insiders · 38 officers · 24 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Ivan Tornos | Chairman, President and CEO | March 6, 2026 M | 83,191 | 0 | 0 | $0 |
| Bryan C Hanson | President and CEO | March 6, 2023 A | 102,797 | 0 | 0 | $0 |
| John Raymond Elliott | Chairman, Pres. & CEO | Feb. 12, 2007 M | 62,751 | 0 | 0 | $0 |
| Suketu Upadhyay | Exec VP, CFO | March 6, 2026 M | 69,485 | 0 | 0 | $0 |
| Florin Daniel P | Exec. VP, CFO | May 8, 2019 G | 25,471 | 0 | 0 | $0 |
| James T Crines | EVP, Finance and CFO | March 19, 2015 M | 56,313 | 0 | 0 | $0 |
| Chintan Desai | President, APAC | Aug. 3, 2026 A | · | 0 | 0 | $0 |
| Sang Yi | Group President, Asia Pacific | May 29, 2026 S | 27,251 | 0 | 3 | $-509,706 |
| Mark Bezjak | President, Americas | March 6, 2025 M | 13,134 | 0 | 0 | $0 |
| Didier Deltort | President, EMEA | Feb. 26, 2021 M | 4,619 | 0 | 0 | $0 |
| Aure Bruneau | Group President | Nov. 11, 2019 M | 757 | 0 | 0 | $0 |
| Robert D. Delp | President, Americas | March 20, 2018 A | · | 0 | 0 | $0 |
| David A. Nolan Jr. | Group President | March 20, 2018 A | 9,102 | 0 | 0 | $0 |
| Daniel E. Williamson | Group President | March 20, 2018 A | 2,000 | 0 | 0 | $0 |
| Adam Rudolph Johnson | Group President | June 24, 2017 M | 11,093 | 0 | 0 | $0 |
| Stuart G. Kleopfer | President, Americas | Aug. 23, 2016 S | 3,000 | 0 | 0 | $0 |
| Stephen H L Ooi | President, Asia Pacific | March 19, 2015 M | 45,411 | 0 | 0 | $0 |
| Joseph A. Cucolo | President, Americas | Oct. 1, 2014 M | 11,226 | 0 | 0 | $0 |
| Jon E Kramer | President, U.S. Sales | Dec. 12, 2008 M | 4,461 | 0 | 0 | $0 |
| Kevin R Thornal | Grp Pres-Global Business | Sept. 11, 2026 S | 0 | 0 | 1 | $-528,978 |
| Chad F Phipps | Senior Vice President, Chief Legal & Corporate Affairs Officer and Secretary | Sept. 4, 2026 S | 65,231 | 0 | 1 | $-295,050 |
| Jehanzeb Noor | Senior Vice President, Chief Strategy, Innovation & Business Development Officer | June 1, 2026 A | 5,151 | 0 | 0 | $0 |
| Paul A Stellato | VP, Controller, CAO | May 1, 2026 A | 5,582 | 0 | 0 | $0 |
| Lori Winkler | SVP and CHRO | March 12, 2026 S | 10,224 | 0 | 1 | $-250,849 |
| Wilfred Van Zuilen | Group Pres, EMEA | March 6, 2026 M | 30,991 | 0 | 0 | $0 |
| Rachel Ellingson | Chief Administrative Officer | Feb. 20, 2025 M | 11,906 | 0 | 0 | $0 |
| Derek M Davis | Interim Controller & CAO | March 1, 2022 A | 6,809 | 0 | 0 | $0 |
| Carrie Ann Nichol | VP, Controller & CAO | Oct. 1, 2021 M | 338 | 0 | 0 | $0 |
| Tony W. Collins | VP, Controller and CAO | July 31, 2018 M | 368 | 0 | 0 | $0 |
| Katarzyna Mazur-Hofsaess | Pres., Eur., M. East & Afr. | May 22, 2018 M | 16,682 | 0 | 0 | $0 |
| Jeffery A Mccaulley | Pres - Zimmer Reconstructive | Jan. 8, 2014 M | 5,211 | 0 | 0 | $0 |
| Jeffrey B Paulsen | Group Pres., Global Businesses | March 16, 2013 M | 6,095 | 0 | 0 | $0 |
| Cheryl R Blanchard | Sr. VP, Chief Scientific Off. | March 19, 2012 A | 18,357 | 0 | 0 | $0 |
| Mark C Throdahl | Group Pres - Global Business | June 12, 2009 D | 844 | 0 | 0 | $0 |
| Sheryl L Conley | Group Pres., Americas & Mktg. | Feb. 12, 2008 A | 2,559 | 0 | 0 | $0 |
| Sam R Leno | EVP | May 4, 2007 D | 27,513 | 0 | 0 | $0 |
| Richard Fritschi | Pres. Zimmer Europe & Austral. | Jan. 18, 2005 A | · | 0 | 0 | $0 |
| Bruce Edward Peterson | Chairman, Zimmer Americas | March 17, 2004 M | 17,975 | 0 | 0 | $0 |
| Louis Shapiro | Director | Sept. 30, 2026 A | · | 0 | 0 | $0 |
| Devdatt Kurdikar | Director | Sept. 30, 2026 A | · | 0 | 0 | $0 |
| Sreelakshmi Kolli | Director | Sept. 30, 2026 A | 1,000 | 0 | 0 | $0 |
| Maria Teresa Hilado | Director | Sept. 30, 2026 A | 1,650 | 0 | 0 | $0 |
| Michael J. Farrell | Director | Sept. 30, 2026 A | 2,000 | 0 | 0 | $0 |
| Robert Hagemann | Director | Sept. 30, 2026 A | 4,000 | 0 | 0 | $0 |
| HIGGINS ARTHUR J | Director | Sept. 30, 2026 A | 3,400 | 0 | 0 | $0 |
| Syed A. Jafry | Director | May 22, 2026 A | 4,060 | 0 | 0 | $0 |
| Betsy J Bernard | Director | May 22, 2026 A | 5,271 | 0 | 0 | $0 |
| Christopher B Begley | Director | March 31, 2025 A | 3,540 | 0 | 0 | $0 |
| Michael W Michelson | Director | May 10, 2024 A | 3,385 | 0 | 0 | $0 |
| Gail Boudreaux | Director | March 31, 2021 A | 2,095 | 0 | 0 | $0 |
| Larry C Glasscock | Director | May 8, 2020 A | 10,861 | 0 | 0 | $0 |
| Jeffrey K. Rhodes | Director | March 31, 2018 A | · | 0 | 0 | $0 |
| Cecil B Pickett | Director | May 12, 2017 A | · | 0 | 0 | $0 |
| Paul Bisaro | Director | March 31, 2017 A | · | 0 | 0 | $0 |
| John L Mcgoldrick | Director | May 7, 2013 A | 11,332 | 0 | 0 | $0 |
| Marc N Casper | Director | March 31, 2013 A | · | 0 | 0 | $0 |
| Augustus A White | Director | May 3, 2010 A | 0 | 0 | 0 | $0 |
| Stuart Essig | Director | May 5, 2008 A | · | 0 | 0 | $0 |
| Regina E Herzlinger | Director | May 2, 2005 A | 40 | 0 | 0 | $0 |
| David C Dvorak | · | April 27, 2017 M | 294,555 | 0 | 0 | $0 |
| LVB Acquisition Holding, LLC | · | Feb. 4, 2016 J | 0 | 0 | 0 | $0 |
| Bruno A Melzi | · | March 16, 2013 M | 11,005 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 119 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IHI · iShares Trust | 2.69% | 924,883 SH | Sept. 11, 2026 | Daily |
| FXH · First Trust Exchange-Traded AlphaDE… | 2.47% | 275,654 NS | July 31, 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.54% | 152,036 SH | Oct. 2, 2026 | Daily |
| FTA · First Trust Exchange-Traded AlphaDE… | 0.94% | 139,642 NS | July 31, 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 0.94% | 4,287 NS | July 31, 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0.49% | 81,838 NS | July 31, 2026 | N-PORT |
| UPSD · ETF Series Solutions | 0.47% | 5,916 NS | July 31, 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0.47% | 8,435 NS | July 31, 2026 | N-PORT |
| SOVF · Elevation Series Trust | 0.41% | 3,781 NS | July 31, 2026 | N-PORT |
| NUDV · Nushares ETF Trust | 0.40% | 2,152 NS | July 31, 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0.34% | 64,683 SH | Oct. 2, 2026 | Daily |
| IYH · iShares Trust | 0.29% | 113,463 SH | Sept. 11, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.26% | 91,889 NS | July 31, 2026 | N-PORT |
| IMCV · iShares Trust | 0.25% | 31,505 SH | Sept. 11, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.25% | 581,880 SH | Aug. 19, 2026 | Daily |
| REVS · Columbia ETF Trust I | 0.24% | 8,508 NS | July 31, 2026 | N-PORT |
| IXJ · iShares Trust | 0.23% | 101,995 SH | Sept. 11, 2026 | Daily |
| SIZE · iShares Trust | 0.21% | 9,696 SH | Sept. 11, 2026 | Daily |
| CURE · Direxion Shares ETF Trust | 0.21% | 3,807 NS | July 31, 2026 | N-PORT |
| EQIN · Columbia ETF Trust I | 0.19% | 6,205 NS | July 31, 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0.19% | 2,063,000 SH | Oct. 2, 2026 | Daily |
| EUSA · iShares, Inc. | 0.19% | 38,732 SH | Sept. 11, 2026 | Daily |
| VLUE · iShares Trust | 0.18% | 191,362 SH | Sept. 11, 2026 | Daily |
| VBR · VANGUARD INDEX FUNDS | 0.18% | 1,408,631 SH | Aug. 19, 2026 | Daily |
| IWS · iShares Trust | 0.18% | 289,171 SH | Sept. 11, 2026 | Daily |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0.16% | 220,000 | Oct. 2, 2026 | Daily |
| RECS · Columbia ETF Trust I | 0.16% | 96,586 NS | July 31, 2026 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0.15% | 13,402 NS | July 31, 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.15% | 15,020 SH | Aug. 19, 2026 | Daily |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0.15% | 4,099,000 | Oct. 2, 2026 | Daily |
| VOE · VANGUARD INDEX FUNDS | 0.14% | 621,372 SH | Aug. 19, 2026 | Daily |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0.14% | 6,247,000 | Oct. 1, 2026 | Daily |
| IWR · iShares Trust | 0.13% | 792,254 SH | Sept. 11, 2026 | Daily |
| IMCB · iShares Trust | 0.12% | 22,655 SH | Sept. 11, 2026 | Daily |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0.12% | 4,049,000 | Oct. 1, 2026 | Daily |
| XOEF · iShares Trust | 0.10% | 248 SH | Sept. 11, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.10% | 2,218,373 SH | Aug. 19, 2026 | Daily |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.09% | 8,178 SH | Oct. 2, 2026 | Daily |
| CATH · Global X Funds | 0.09% | 11,989 NS | July 31, 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0.08% | 2,097,251 SH | Aug. 19, 2026 | Daily |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.08% | 8,286 SH | Oct. 2, 2026 | Daily |
| DFUV · Dimensional ETF Trust | 0.07% | 118,337 NS | July 31, 2026 | N-PORT |
| USXF · iShares Trust | 0.07% | 11,458 SH | Sept. 11, 2026 | Daily |
| PRF · Invesco Exchange-Traded Fund Trust | 0.06% | 70,147 SH | Oct. 2, 2026 | Daily |
| DFSU · Dimensional ETF Trust | 0.06% | 14,595 NS | July 31, 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.06% | 44,339 SH | Aug. 19, 2026 | Daily |
| IVE · iShares Trust | 0.06% | 321,014 SH | Sept. 11, 2026 | Daily |
| IUSV · iShares Trust | 0.06% | 168,895 SH | Sept. 11, 2026 | Daily |
| DXUV · Dimensional ETF Trust | 0.06% | 3,302 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.06% | 284,411 NS | July 31, 2026 | N-PORT |
| IQSU · New York Life Investments ETF Trust | 0.06% | 1,943 NS | July 31, 2026 | N-PORT |
| CHRI · Global X Funds | 0.06% | 47 NS | July 31, 2026 | N-PORT |
| ILCV · iShares Trust | 0.05% | 7,599 SH | Sept. 11, 2026 | Daily |
| SUSL · iShares Trust | 0.05% | 6,763 SH | Sept. 11, 2026 | Daily |
| DSI · iShares Trust | 0.05% | 29,825 SH | Sept. 11, 2026 | Daily |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.05% | 116,793 SH | Aug. 19, 2026 | Daily |
| DCOR · Dimensional ETF Trust | 0.05% | 17,680 NS | July 31, 2026 | N-PORT |
| IWD · iShares Trust | 0.05% | 429,649 SH | Sept. 11, 2026 | Daily |
| EGLE · Global X Funds | 0.04% | 10 NS | July 31, 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0.04% | 5 NS | July 31, 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.04% | 44,794 SH | Oct. 2, 2026 | Daily |
| DFLV · Dimensional ETF Trust | 0.03% | 24,552 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.03% | 45,016 NS | July 31, 2026 | N-PORT |
| XYLG · Global X Funds | 0.03% | 226 NS | July 31, 2026 | N-PORT |
| TOPC · iShares Trust | 0.03% | 117 SH | Sept. 11, 2026 | Daily |
| XCLR · Global X Funds | 0.03% | 12 NS | July 31, 2026 | N-PORT |
| XRMI · Global X Funds | 0.03% | 163 NS | July 31, 2026 | N-PORT |
| XVV · iShares Trust | 0.03% | 2,222 SH | Sept. 11, 2026 | Daily |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.03% | 5,778 SH | Oct. 2, 2026 | Daily |
| VOO · VANGUARD INDEX FUNDS | 0.03% | 5,022,961 SH | Aug. 19, 2026 | Daily |
| VTV · VANGUARD INDEX FUNDS | 0.03% | 920,066 SH | Aug. 19, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.03% | 43,771 SH | Aug. 19, 2026 | Daily |
| TOV · EA Series Trust | 0.03% | 921 NS | July 31, 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0.03% | 17,261 NS | July 31, 2026 | N-PORT |
| XYLD · Global X Funds | 0.03% | 10,147 NS | July 31, 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0.03% | 10,046 NS | July 31, 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.03% | 26,677 NS | July 31, 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0.03% | 3,273 NS | July 31, 2026 | N-PORT |
| ILCB · iShares Trust | 0.03% | 3,851 SH | Sept. 11, 2026 | Daily |
| DFUS · Dimensional ETF Trust | 0.03% | 60,829 NS | July 31, 2026 | N-PORT |
| IVV · iShares Trust | 0.03% | 2,438,768 SH | Sept. 11, 2026 | Daily |
| XTR · Global X Funds | 0.03% | 14 NS | July 31, 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0.03% | 1,142 SH | Oct. 2, 2026 | Daily |
| SPUU · Direxion Shares ETF Trust | 0.03% | 730 NS | July 31, 2026 | N-PORT |
| IYY · iShares Trust | 0.03% | 8,407 SH | Sept. 11, 2026 | Daily |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0.03% | 33,488 SH | Oct. 2, 2026 | Daily |
| IWB · iShares Trust | 0.03% | 133,637 SH | Sept. 11, 2026 | Daily |
| QDPL · Pacer Funds Trust | 0.03% | 4,637 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.03% | 54,548 SH | Sept. 11, 2026 | Daily |
| USCL · iShares Trust | 0.03% | 7,635 SH | Sept. 11, 2026 | Daily |
| ITOT · iShares Trust | 0.02% | 251,793 SH | Sept. 11, 2026 | Daily |
| HCMT · Direxion Shares ETF Trust | 0.02% | 1,351 NS | July 31, 2026 | N-PORT |
| ACVF · ETF Opportunities Trust | 0.02% | 350 NS | July 31, 2026 | N-PORT |
| TOK · iShares Trust | 0.02% | 545 SH | Sept. 11, 2026 | Daily |
| SPXL · Direxion Shares ETF Trust | 0.02% | 15,123 NS | July 31, 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0.02% | 143 SH | Oct. 2, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.02% | 6,142,505 SH | Aug. 19, 2026 | Daily |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.02% | 31,872 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.02% | 16,297 SH | Aug. 19, 2026 | Daily |
| URTH · iShares, Inc. | 0.02% | 17,242 SH | Sept. 11, 2026 | Daily |
| VOXP · Advisors Series Trust | 0.02% | 12 NS | July 31, 2026 | N-PORT |
| TILT · FlexShares Trust | 0.02% | 4,266 NS | July 31, 2026 | N-PORT |
| ACWI · iShares Trust | 0.02% | 64,570 SH | Sept. 11, 2026 | Daily |
| DFAT · Dimensional ETF Trust | 0.02% | 23,873 NS | July 31, 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.01% | 5,624 SH | Oct. 2, 2026 | Daily |
| VV · VANGUARD INDEX FUNDS | 0.01% | 113,321 SH | Aug. 19, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 168,446 SH | Aug. 19, 2026 | Daily |
| DYNF · BlackRock ETF Trust | 0.00% | 80 SH | Sept. 2, 2026 | Daily |
| FTLS · First Trust Exchange-Traded Fund III | -0.18% | -46,926 NS | July 31, 2026 | N-PORT |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| BND · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | July 30, 2026 | Daily |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | July 30, 2026 | Daily |
| VCEB · VANGUARD WORLD FUND | · | · | July 30, 2026 | Daily |
ZBH Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 33 analysts
HOLD
Median target
$106.00
+20.1%
3 9.1%
Strong Buy
8 24.2%
Buy
22 66.7%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
21 analysts · 2026-09-29Mean target $107.57 +21.8%
← Below all targets
Current price $88.29
Low$93.00
Mean$107.57
High$130.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
| BDX | · | 25.3 | 8.2% | 7.7% | 6.5% | · |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| GMED | · | 22.3 | 16.7% | 18.3% | 12.1% | · |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
Latest News Recent headlines mentioning this company
Trading Signals Recent buy/sell signals with entry price and risk/reward ratio
No open signal right now — no card is filled, and that's honest.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 5, 2026